On Sept. 1, 2020, Roche announced FDA approval for the cobasﾮ HIV-1/HIV-2 Qualitative Test for use on the fully automated cobasﾮ 6800/8800 Systems in the U.S. The test provides healthcare professionals with a single result to confirm HIV diagnosis and differentiate HIV-1 and HIV-2, an important distinction needed to identify appropriate treatment options.